Back to Journals » Drug Design, Development and Therapy » Volume 15
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Profile of Enfortumab Vedotin in the Treatment of Urothelial Carcinoma: The Evidence to Date
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,411 | Dovepress* | 5,117+ | 571 | 5,688 | |
PubMed Central* | 2,294 | 371 | 2,665 | ||
Totals | 7,411 | 942 | 8,353 | ||
*Since 11 February 2021 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar